MedVantage Partners with TransAct to Enhance Food Safety
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 19 2026
0mins
Source: Newsfilter
- Significant Partnership Success: MedVantage's OEM partnership with TransAct has entered its third year, successfully driving the widespread adoption of TransAct's hardware and SaaS solutions in the U.S. healthcare and food service sectors, significantly enhancing customer food safety and compliance.
- Positive Customer Feedback: Since the partnership began, customers have reported improvements in food safety and labeling accuracy, reduced labor time associated with manual processes, enhanced consistency across multi-site operations, and improved regulatory compliance and audit readiness, directly boosting operational efficiency.
- Strong Market Demand: The General Manager of MedVantage noted that there has been strong demand from customers for smarter, more automated back-of-house solutions over the past two years, with TransAct's technology enabling them to deliver a differentiated offering that addresses critical operational challenges while achieving tangible ROI.
- Innovation Driving Growth: The OEM collaboration allows MedVantage to integrate TransAct's award-winning technology into its broader portfolio of solutions, further supporting customers in innovative ways to improve food safety and compliance, thereby enhancing market competitiveness.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TACT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TACT
Wall Street analysts forecast TACT stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.890
Low
5.00
Averages
5.00
High
5.00
Current: 3.890
Low
5.00
Averages
5.00
High
5.00
No data
About TACT
TransAct Technologies Incorporated develops and sells software-driven technology and printing solutions for markets, including food service, casino, and gaming, and point of sale (POS) automation. The Company’s solutions are designed based on customer requirements and are sold under the BOHA!, AccuDate, EPICENTRAL, Epic and Ithaca brands. Through the TransAct Services Group, it also provides customers with a range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. Its primary offering in the food service technology market is its line of BOHA! Products. In the POS market, it sells a printer utilizing thermal printing technology. It sells several models of printers used in slot machines and video lottery terminals (VLTs) and other gaming machines that print tickets or receipts instead of issuing coins at casinos, racetracks, and other gaming venues worldwide. It also offers a software solution, the EPICENTRAL Print System.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
MedVantage Partners with TransAct to Enhance Food Safety
- Significant Partnership Success: MedVantage's OEM partnership with TransAct has entered its third year, successfully driving the widespread adoption of TransAct's hardware and SaaS solutions in the U.S. healthcare and food service sectors, significantly enhancing customer food safety and compliance.
- Positive Customer Feedback: Since the partnership began, customers have reported improvements in food safety and labeling accuracy, reduced labor time associated with manual processes, enhanced consistency across multi-site operations, and improved regulatory compliance and audit readiness, directly boosting operational efficiency.
- Strong Market Demand: The General Manager of MedVantage noted that there has been strong demand from customers for smarter, more automated back-of-house solutions over the past two years, with TransAct's technology enabling them to deliver a differentiated offering that addresses critical operational challenges while achieving tangible ROI.
- Innovation Driving Growth: The OEM collaboration allows MedVantage to integrate TransAct's award-winning technology into its broader portfolio of solutions, further supporting customers in innovative ways to improve food safety and compliance, thereby enhancing market competitiveness.
See More
Transact Technologies Reports 10% Sales Growth in Q1
- Sales Performance Boost: Transact Technologies Inc reported Q1 net sales of $14.4 million, reflecting a 10% year-over-year increase, showcasing the company's strong market performance, particularly in its strategic focus on software revenue.
- Software Revenue Growth: The company achieved a 23% increase in recurring FST revenue, reaching $3.3 million, indicating the success of its transition to a recurring revenue model, which is expected to further drive future revenue growth.
- Strong Casino and Gaming Sales: Casino and gaming sales reached $8.3 million, up 24% year-over-year, reflecting robust domestic and international demand, which is expected to continue contributing to the company's cash flow.
- Upgraded Profit Expectations: The company raised its 2026 net sales outlook to between $55 million and $57 million, while also increasing its adjusted EBITDA forecast to between $1 million and $1.75 million, demonstrating confidence in future performance.
See More
TransAct Technologies Q1 2026 Earnings Call Highlights
- Significant Sales Growth: TransAct Technologies reported total net sales of $14.4 million for Q1 2026, reflecting a 10% year-over-year increase, indicating strong growth potential in the foodservice technology sector that is expected to drive future revenue growth.
- Adjusted EBITDA Improvement: The company reported an adjusted EBITDA of $1.4 million for the first quarter, raising its previous guidance range of $800,000 to $1.5 million, showcasing management's confidence in profitability and execution capabilities.
- Increase in Online Terminals: By the end of Q1, TransAct had 19,959 online terminals, with management planning to enhance revenue contributions through effective monetization strategies, which is expected to strengthen the company's competitive position in the market.
- Optimistic Software Revenue Outlook: The company aims to increase its monthly software revenue target to $100 to $200 per machine, and with the BOHA! software's earlier launch, it is anticipated to further drive long-term recurring revenue growth.
See More
TransAct Technologies CFO Retirement and Successor Announcement
- Executive Transition: TransAct Technologies announced the retirement of longtime CFO Steven A. DeMartino effective June 30, marking a significant leadership change after nearly 30 years with the company.
- New CFO Appointment: Robert Campbell has been named as the new CFO, having served as controller since 2022, and will also take on the roles of secretary and treasurer, which is expected to enhance the company's financial management.
- Strategic Alignment: CEO John Dillon stated that this leadership transition supports the company's strategy to expand recurring revenue through its BOHA! cloud-based SaaS platform, indicating a strong focus on future growth.
- Advisory Role: DeMartino will remain in an advisory capacity until the end of 2026 to assist with the transition, ensuring stability and continuity for the company during this period of change.
See More
Transact Technologies Reports Strong Q4 2025 Earnings
- Significant Sales Growth: Transact Technologies reported total net sales of $11.5 million in Q4 2025, a 12% increase from $10.2 million in Q4 2024, with full-year sales reaching $51.5 million, up 19% from 2024, indicating effective sales strategies and strong market demand.
- FST Revenue Increase: The FST net sales for Q4 2025 were $4.8 million, a 12% year-over-year increase, while full-year FST sales reached $19.3 million, up 20%, demonstrating the company's sustained growth potential in the foodservice technology sector.
- Strong Cash Flow: By the end of 2025, Transact Technologies had over $20 million in cash, an increase of $6 million from 2024, reflecting a solid financial position that provides ample funding for future investments.
- Improved Adjusted EBITDA: The adjusted EBITDA for Q4 2025 was negative $499,000, an improvement from negative $705,000 in the same quarter last year, while the full-year adjusted EBITDA was positive $1.2 million, indicating a positive shift in the company's profitability outlook.
See More
TransAct Technologies Reports Strong Q4 2025 Earnings with Strategic Focus on Software Growth
- Significant Sales Growth: TransAct achieved net sales of $11.5 million in Q4 2025, a 12% increase year-over-year, with total sales for the year reaching $51.5 million, reflecting a 19% growth compared to 2024, indicating strong market performance and growth potential.
- Software Strategy Priority: CEO John Dillon emphasized that software will serve as the primary growth engine moving forward, with plans to launch TransAct's own BOHA! software version in 2026, and to enhance revenue and market competitiveness through a new application store model and customer migration to a public cloud platform.
- Ongoing Investment and Profit Outlook: Management expects 2026 net sales to be between $55 million and $57 million, with adjusted EBITDA projected between $800,000 and $1.5 million, indicating a commitment to targeted investments in marketing and sales while maintaining fiscal discipline.
- New CMO Appointment: The addition of new Chief Marketing Officer Dana Loof will drive competitive positioning and investor relations, with Dillon noting her priorities will include enhancing brand messaging and lead generation, thereby strengthening the company's market presence.
See More
MedVantage Partners with TransAct to Enhance Food Safety
- Significant Partnership Success: MedVantage's OEM partnership with TransAct has entered its third year, successfully driving the widespread adoption of TransAct's hardware and SaaS solutions in the U.S. healthcare and food service sectors, significantly enhancing customer food safety and compliance.
- Positive Customer Feedback: Since the partnership began, customers have reported improvements in food safety and labeling accuracy, reduced labor time associated with manual processes, enhanced consistency across multi-site operations, and improved regulatory compliance and audit readiness, directly boosting operational efficiency.
- Strong Market Demand: The General Manager of MedVantage noted that there has been strong demand from customers for smarter, more automated back-of-house solutions over the past two years, with TransAct's technology enabling them to deliver a differentiated offering that addresses critical operational challenges while achieving tangible ROI.
- Innovation Driving Growth: The OEM collaboration allows MedVantage to integrate TransAct's award-winning technology into its broader portfolio of solutions, further supporting customers in innovative ways to improve food safety and compliance, thereby enhancing market competitiveness.
See More
Transact Technologies Reports 10% Sales Growth in Q1
- Sales Performance Boost: Transact Technologies Inc reported Q1 net sales of $14.4 million, reflecting a 10% year-over-year increase, showcasing the company's strong market performance, particularly in its strategic focus on software revenue.
- Software Revenue Growth: The company achieved a 23% increase in recurring FST revenue, reaching $3.3 million, indicating the success of its transition to a recurring revenue model, which is expected to further drive future revenue growth.
- Strong Casino and Gaming Sales: Casino and gaming sales reached $8.3 million, up 24% year-over-year, reflecting robust domestic and international demand, which is expected to continue contributing to the company's cash flow.
- Upgraded Profit Expectations: The company raised its 2026 net sales outlook to between $55 million and $57 million, while also increasing its adjusted EBITDA forecast to between $1 million and $1.75 million, demonstrating confidence in future performance.
See More
TransAct Technologies Q1 2026 Earnings Call Highlights
- Significant Sales Growth: TransAct Technologies reported total net sales of $14.4 million for Q1 2026, reflecting a 10% year-over-year increase, indicating strong growth potential in the foodservice technology sector that is expected to drive future revenue growth.
- Adjusted EBITDA Improvement: The company reported an adjusted EBITDA of $1.4 million for the first quarter, raising its previous guidance range of $800,000 to $1.5 million, showcasing management's confidence in profitability and execution capabilities.
- Increase in Online Terminals: By the end of Q1, TransAct had 19,959 online terminals, with management planning to enhance revenue contributions through effective monetization strategies, which is expected to strengthen the company's competitive position in the market.
- Optimistic Software Revenue Outlook: The company aims to increase its monthly software revenue target to $100 to $200 per machine, and with the BOHA! software's earlier launch, it is anticipated to further drive long-term recurring revenue growth.
See More
TransAct Technologies CFO Retirement and Successor Announcement
- Executive Transition: TransAct Technologies announced the retirement of longtime CFO Steven A. DeMartino effective June 30, marking a significant leadership change after nearly 30 years with the company.
- New CFO Appointment: Robert Campbell has been named as the new CFO, having served as controller since 2022, and will also take on the roles of secretary and treasurer, which is expected to enhance the company's financial management.
- Strategic Alignment: CEO John Dillon stated that this leadership transition supports the company's strategy to expand recurring revenue through its BOHA! cloud-based SaaS platform, indicating a strong focus on future growth.
- Advisory Role: DeMartino will remain in an advisory capacity until the end of 2026 to assist with the transition, ensuring stability and continuity for the company during this period of change.
See More
Transact Technologies Reports Strong Q4 2025 Earnings
- Significant Sales Growth: Transact Technologies reported total net sales of $11.5 million in Q4 2025, a 12% increase from $10.2 million in Q4 2024, with full-year sales reaching $51.5 million, up 19% from 2024, indicating effective sales strategies and strong market demand.
- FST Revenue Increase: The FST net sales for Q4 2025 were $4.8 million, a 12% year-over-year increase, while full-year FST sales reached $19.3 million, up 20%, demonstrating the company's sustained growth potential in the foodservice technology sector.
- Strong Cash Flow: By the end of 2025, Transact Technologies had over $20 million in cash, an increase of $6 million from 2024, reflecting a solid financial position that provides ample funding for future investments.
- Improved Adjusted EBITDA: The adjusted EBITDA for Q4 2025 was negative $499,000, an improvement from negative $705,000 in the same quarter last year, while the full-year adjusted EBITDA was positive $1.2 million, indicating a positive shift in the company's profitability outlook.
See More
TransAct Technologies Reports Strong Q4 2025 Earnings with Strategic Focus on Software Growth
- Significant Sales Growth: TransAct achieved net sales of $11.5 million in Q4 2025, a 12% increase year-over-year, with total sales for the year reaching $51.5 million, reflecting a 19% growth compared to 2024, indicating strong market performance and growth potential.
- Software Strategy Priority: CEO John Dillon emphasized that software will serve as the primary growth engine moving forward, with plans to launch TransAct's own BOHA! software version in 2026, and to enhance revenue and market competitiveness through a new application store model and customer migration to a public cloud platform.
- Ongoing Investment and Profit Outlook: Management expects 2026 net sales to be between $55 million and $57 million, with adjusted EBITDA projected between $800,000 and $1.5 million, indicating a commitment to targeted investments in marketing and sales while maintaining fiscal discipline.
- New CMO Appointment: The addition of new Chief Marketing Officer Dana Loof will drive competitive positioning and investor relations, with Dillon noting her priorities will include enhancing brand messaging and lead generation, thereby strengthening the company's market presence.
See More
